<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Crimea Journal of Experimental and Clinical Medicine</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Crimea Journal of Experimental and Clinical Medicine</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Крымский журнал экспериментальной и клинической медицины</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2224-6444</issn>
   <issn publication-format="online">2224-6452</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">106782</article-id>
   <article-id pub-id-type="doi">10.29039/2224-6444-2025-15-1-64-70</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>ОБЗОРЫ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>REVIEWS</subject>
    </subj-group>
    <subj-group>
     <subject>ОБЗОРЫ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">MORPHOLOGICAL CHANGES IN THE KIDNEYS IN FABRY DISEASE</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>МОРФОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ В ПОЧКАХ ПРИ БОЛЕЗНИ ФАБРИ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Мяндина</surname>
       <given-names>Г. И.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Myandina</surname>
       <given-names>G. I.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Цибулевский</surname>
       <given-names>А. Ю.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Cibulevskiy</surname>
       <given-names>A. Yu.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Дубовая</surname>
       <given-names>Т. К.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Dubovaya</surname>
       <given-names>T. K.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Салюков</surname>
       <given-names>Р. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Salyukov</surname>
       <given-names>R. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Попов</surname>
       <given-names>С. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Popov</surname>
       <given-names>S. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-5"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Кульченко</surname>
       <given-names>Н. Г.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kul'chenko</surname>
       <given-names>N. G.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-6"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Страчук</surname>
       <given-names>А. Г.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Strachuk</surname>
       <given-names>A. G.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-7"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Московский медицинский  университет &quot;РЕАВИЗ&quot;</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Московский медицинский  университет &quot;РЕАВИЗ&quot;</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-5">
    <aff>
     <institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-6">
    <aff>
     <institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-7">
    <aff>
     <institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Российский университет дружбы народов имени Патриса Лумумбы</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2025-11-18T00:00:00+03:00">
    <day>18</day>
    <month>11</month>
    <year>2025</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-11-18T00:00:00+03:00">
    <day>18</day>
    <month>11</month>
    <year>2025</year>
   </pub-date>
   <volume>15</volume>
   <issue>1</issue>
   <fpage>64</fpage>
   <lpage>70</lpage>
   <history>
    <date date-type="received" iso-8601-date="2025-11-18T00:00:00+03:00">
     <day>18</day>
     <month>11</month>
     <year>2025</year>
    </date>
   </history>
   <self-uri xlink:href="https://docs.yandex.ru/docs/view?url=ya-browser%3A%2F%2F4DT1uXEPRrJRXlUFoewruHTUArnRJf7nJeCxSHH0G9nXc47Y5ozrm-GKWs5HSV9iFzQBXVCOrnVBI4iiCEOVh8zWn-kWHeSbSTbp7X0KpzbDB0ZBgFkoI8OvPV2gxbeSoBwQmd75Qk7vIoVLs8bP_g%3D%3D%3Fsign%3D0McjbqGUfB3t8oBzjd3FJJymuQ01YtYCnf-c-dCjKrQ%3D&amp;name=9_&#x41C;&#x44F;&#x43D;&#x434;&#x438;&#x43D;&#x430;.doc&amp;nosw=1">https://docs.yandex.ru/docs/view?url=ya-browser%3A%2F%2F4DT1uXEPRrJRXlUFoewruHTUArnRJf7nJeCxSHH0G9nXc47Y5ozrm-GKWs5HSV9iFzQBXVCOrnVBI4iiCEOVh8zWn-kWHeSbSTbp7X0KpzbDB0ZBgFkoI8OvPV2gxbeSoBwQmd75Qk7vIoVLs8bP_g%3D%3D%3Fsign%3D0McjbqGUfB3t8oBzjd3FJJymuQ01YtYCnf-c-dCjKrQ%3D&amp;name=9_Мяндина.doc&amp;nosw=1</self-uri>
   <abstract xml:lang="ru">
    <p>Болезнь Фабри, является редким наследственным генетическим заболеванием, вызванным дефицитом лизосомального фермента альфа-галактозидазы А (α-Gal A). Этот фермент отвечает за расщепление жиров, а именно глоботриаозилцерамида (GL-3). При дефиците или отсутствии фермента α-Gal A липидные включения накапливается в клетках различных органов, в том числе и почках, что приводит к нарушению их функции. Отложение GL-3 в виде жировых включений происходит в различных клетках нефрона, включая подоциты, эндотелиальные клетки клубочков, мезангиальные клетки и эпителиальные клетки канальцев, что можно выявить при морфологическом изучении биоптатов почки. Накопление GL-3 способствует развитию местного воспаления, что приводит к утолщению висцерального и париетального листков капсулы Шумлянского–Боумена. Патоморфологические изменения в почках при болезни Фабри приводят к характерным клиническим признакам заболевания: протеинурия, гематурия, снижение скорости клубочковой фильтрации, вплоть до развития хронической болезни почек и летального исхода. Заключение. Длительно существующая и прогрессирующая протеинурия у молодых лиц мужского пола является показанием к выполнению биопсии почки с последующим морфологическим анализом биоптатов с целью дифференциальной диагностики болезни Фабри и нефропатий другого генеза.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Fabry Disease, is a rare, inherited genetic disorder caused by a deficiency of the enzyme alpha-galactosidase A (α-Gal A). This enzyme is responsible for breaking down a fatty substance called globotriaosylceramide (GL-3). When the enzyme is deficient or absent, GL-3 accumulates in various cells throughout the body, leading to a range of symptoms and organ damage. Deposition of GL-3 in the form of lipid inclusions occurs in various nephron cells, including podocytes, glomerular endothelial cells, mesangial cells, and tubule epithelial cells, which can be detected by morphological examination of kidney biopsies. The accumulation of GL-3 contributes to the development of local inflammation, which leads to thickening of the visceral and parietal leaves of the Bowman capsule. Pathomorphological changes in the kidneys in Fabry’s disease lead to characteristic clinical signs of the disease: proteinuria, hematuria, de creased glomerular filtration rate, up to the development of chronic kidney disease and death. Conclusion. Long-term and progressive proteinuria in young males is an indication for performing a kidney biopsy followed by morphological  analysis of biopsies for the purpose of differential diagnosis of Fabry disease and nephropathies of another genesis.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>болезнь Фабри</kwd>
    <kwd>генетическое заболевание</kwd>
    <kwd>хроническая болезнь почек</kwd>
    <kwd>морфологические изменения в почке</kwd>
    <kwd>почечный клубочек</kwd>
    <kwd>фильтрационный барьер</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>Fabry Disease</kwd>
    <kwd>genetic disease</kwd>
    <kwd>chronic kidney disease</kwd>
    <kwd>morphological changes in the  kidney</kwd>
    <kwd>renal glomerulus</kwd>
    <kwd>filtration barrier.</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lerario S., Monti L., Ambrosetti I., Luglio A. Pietra A., Aiello V.,Montanari F., Bellasi A., Zaza G., Galante A., Salera D., Capelli I., La Manna G.,Provenzano M. Fabry disease: a rare disorder calling for personalized medicine. Int</mixed-citation>
     <mixed-citation xml:lang="en">Lerario S., Monti L., Ambrosetti I., Luglio A. Pietra A., Aiello V.,Montanari F., Bellasi A., Zaza G., Galante A., Salera D., Capelli I., La Manna G.,Provenzano M. Fabry disease: a rare disorder calling for personalized medicine. Int</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Coelho-Ribeiro B., Silva H. G., Sampaio-Marques B., Fraga A. G., Azevedo O., Pedrosa J., Ludovico P. Inflammation and Exosomes in FabryDisease Pathogenesis. Cells. 2024 Apr 9;13(8):654. doi:10.3390/cells13080654.</mixed-citation>
     <mixed-citation xml:lang="en">Coelho-Ribeiro B., Silva H. G., Sampaio-Marques B., Fraga A. G., Azevedo O., Pedrosa J., Ludovico P. Inflammation and Exosomes in FabryDisease Pathogenesis. Cells. 2024 Apr 9;13(8):654. doi:10.3390/cells13080654.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Beck M., Ramaswami U., Hernberg-Ståhl E., Hughes D. A., Kampmann C., Mehta A. B., Nicholls K., Niu D. M., Pintos-Morell G., Reisin R., West M. L., Schenk J., Anagnostopoulou C., Botha J., Giugliani R. Twenty years</mixed-citation>
     <mixed-citation xml:lang="en">Beck M., Ramaswami U., Hernberg-Ståhl E., Hughes D. A., Kampmann C., Mehta A. B., Nicholls K., Niu D. M., Pintos-Morell G., Reisin R., West M. L., Schenk J., Anagnostopoulou C., Botha J., Giugliani R. Twenty years</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Majid H., Verma N., Bhandari S., Gupta S., Nidhi. A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry's Disease. Expert Opin Pharmacother. 2024 Apr;25(6):769-782.</mixed-citation>
     <mixed-citation xml:lang="en">Majid H., Verma N., Bhandari S., Gupta S., Nidhi. A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry's Disease. Expert Opin Pharmacother. 2024 Apr;25(6):769-782.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Studenikin V. M. What is known about Fabry disease in the 21st century. Polyclinic. 2023;5:37-40.</mixed-citation>
     <mixed-citation xml:lang="en">Studenikin V. M. What is known about Fabry disease in the 21st century. Polyclinic. 2023;5:37-40.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Urtis M., Cavaliere C., Vilardo V., Paganini C., Smirnova A., Giorgianni C., Di Toro A., Chiapparini L., Pellegrini C., Grasso M., Arbustini E.Unambiguous Interpretation of the Pathogenicity of the GLA c.547+3A&gt;G Variant</mixed-citation>
     <mixed-citation xml:lang="en">Urtis M., Cavaliere C., Vilardo V., Paganini C., Smirnova A., Giorgianni C., Di Toro A., Chiapparini L., Pellegrini C., Grasso M., Arbustini E.Unambiguous Interpretation of the Pathogenicity of the GLA c.547+3A&gt;G Variant</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Greillier S., Daniel L., Caillaud C., Dussol B., Touchard G., Goujon J. M., Jourde-Chiche N., Bobot M. First phenotypic description of a female patient with c.610 T &gt; C variant of GLA: a renal-predominant presentation of Fabry</mixed-citation>
     <mixed-citation xml:lang="en">Greillier S., Daniel L., Caillaud C., Dussol B., Touchard G., Goujon J. M., Jourde-Chiche N., Bobot M. First phenotypic description of a female patient with c.610 T &gt; C variant of GLA: a renal-predominant presentation of Fabry</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Izhar R., Borriello M., La Russa A., Di Paola R., De A., Capasso G.,Ingrosso D., Perna A. F., Simeoni M. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations. Genes (Basel). 2023 Dec</mixed-citation>
     <mixed-citation xml:lang="en">Izhar R., Borriello M., La Russa A., Di Paola R., De A., Capasso G.,Ingrosso D., Perna A. F., Simeoni M. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations. Genes (Basel). 2023 Dec</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wagenhäuser L., Rickert V., Sommer C., Wanner C., Nordbeck P.,Rost S., Üçeyler N. X-chromosomal inactivation patterns in women with Fabry disease. Mol Genet Genomic Med. 2022 Sep;10(9):e2029.</mixed-citation>
     <mixed-citation xml:lang="en">Wagenhäuser L., Rickert V., Sommer C., Wanner C., Nordbeck P.,Rost S., Üçeyler N. X-chromosomal inactivation patterns in women with Fabry disease. Mol Genet Genomic Med. 2022 Sep;10(9):e2029.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rossanti R., Nozu K., Fukunaga A., Nagano C., Horinouchi T.,Yamamura T., Sakakibara N., Minamikawa S., Ishiko S., Aoto Y., Okada E.,Ninchoji T., Kato N., Maruyama S., Kono K., Nishi S., Iijima K., Fujii H. X- chromosome</mixed-citation>
     <mixed-citation xml:lang="en">Rossanti R., Nozu K., Fukunaga A., Nagano C., Horinouchi T.,Yamamura T., Sakakibara N., Minamikawa S., Ishiko S., Aoto Y., Okada E.,Ninchoji T., Kato N., Maruyama S., Kono K., Nishi S., Iijima K., Fujii H. X- chromosome</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Bernardes T. P., Foresto R. D., Kirsztajn G. M. Fabry disease: genetics, pathology, and treatment. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s10-s16. doi:10.1590/1806-9282.66.S1.10.</mixed-citation>
     <mixed-citation xml:lang="en">Bernardes T. P., Foresto R. D., Kirsztajn G. M. Fabry disease: genetics, pathology, and treatment. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s10-s16. doi:10.1590/1806-9282.66.S1.10.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lenders M., Brand E. Precision medicine in Fabry disease. Nephrol Dial Transplant. 2021 Jun 22;36(Suppl 2):14-23. doi:10.1093/ndt/gfab038.</mixed-citation>
     <mixed-citation xml:lang="en">Lenders M., Brand E. Precision medicine in Fabry disease. Nephrol Dial Transplant. 2021 Jun 22;36(Suppl 2):14-23. doi:10.1093/ndt/gfab038.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Esposito P., Caputo C., Repetto M., Somaschini A., Pietro B., Colomba P., Zizzo C., Parodi A., Zanetti V., Canepa M., Eustachi V., Sanguineri F., Mandich P., Viazzi F. Diagnosing Fabry nephropathy: the challenge of multiple</mixed-citation>
     <mixed-citation xml:lang="en">Esposito P., Caputo C., Repetto M., Somaschini A., Pietro B., Colomba P., Zizzo C., Parodi A., Zanetti V., Canepa M., Eustachi V., Sanguineri F., Mandich P., Viazzi F. Diagnosing Fabry nephropathy: the challenge of multiple</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Germain D. P., Altarescu G., Barriales-Villa R., Mignani R., Pawlaczyk K., Pieruzzi F., Terryn W., Vujkovac B., Ortiz A. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry</mixed-citation>
     <mixed-citation xml:lang="en">Germain D. P., Altarescu G., Barriales-Villa R., Mignani R., Pawlaczyk K., Pieruzzi F., Terryn W., Vujkovac B., Ortiz A. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Abensur H., Reis M. A. Acometimento renal na doença de Fabry. J Bras Nefrol. 2016;382):245-54.</mixed-citation>
     <mixed-citation xml:lang="en">Abensur H., Reis M. A. Acometimento renal na doença de Fabry. J Bras Nefrol. 2016;382):245-54.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhang R., Chen Z., Lang Y., Shao S., Cai Y., You Q., Sun Y., Wang S., Shi X., Liu Z., Guo W., Han Y., Shao L. Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report. Ren Fail. 2020 Nov;42</mixed-citation>
     <mixed-citation xml:lang="en">Zhang R., Chen Z., Lang Y., Shao S., Cai Y., You Q., Sun Y., Wang S., Shi X., Liu Z., Guo W., Han Y., Shao L. Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report. Ren Fail. 2020 Nov;42</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Fogo A. B., Bostad L., Svarstad E., Cook W. J., Moll S., Barbey F., Geldenhuys L., West M., Ferluga D., Vujkovac B., Howie A. J., Burns A., Reeve R., Waldek S., Noel L. H., Grunfeld J. P., Valbuena C., Oliveira J. P., Muller</mixed-citation>
     <mixed-citation xml:lang="en">Fogo A. B., Bostad L., Svarstad E., Cook W. J., Moll S., Barbey F., Geldenhuys L., West M., Ferluga D., Vujkovac B., Howie A. J., Burns A., Reeve R., Waldek S., Noel L. H., Grunfeld J. P., Valbuena C., Oliveira J. P., Muller</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cathro H. P., Shen S. S., Truong L. D. Diagnostic histochemistry in medical diseases of the kidney. Semin Diagn Pathol. 2018 Nov;35(6):360-369. doi:10.1053/j.semdp.2018.10.001</mixed-citation>
     <mixed-citation xml:lang="en">Cathro H. P., Shen S. S., Truong L. D. Diagnostic histochemistry in medical diseases of the kidney. Semin Diagn Pathol. 2018 Nov;35(6):360-369. doi:10.1053/j.semdp.2018.10.001</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Huang X., Zhang R. Zebra Bodies in the Kidney. N Engl J Med. 2020 Jul 2;383(1):e2. doi:10.1056/NEJMicm1912889.</mixed-citation>
     <mixed-citation xml:lang="en">Huang X., Zhang R. Zebra Bodies in the Kidney. N Engl J Med. 2020 Jul 2;383(1):e2. doi:10.1056/NEJMicm1912889.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shima H., Tsukimura T., Shiga T., Togawa T., Sakuraba H., Doi T., Ikeda Y., Okamoto T., Yoshikawa Y., Kimura T., Iwase T., Inoue T., Tashiro M., Okada K., Minakuchi J. Effects of switching from agalsidase-α to agalsidase-β</mixed-citation>
     <mixed-citation xml:lang="en">Shima H., Tsukimura T., Shiga T., Togawa T., Sakuraba H., Doi T., Ikeda Y., Okamoto T., Yoshikawa Y., Kimura T., Iwase T., Inoue T., Tashiro M., Okada K., Minakuchi J. Effects of switching from agalsidase-α to agalsidase-β</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Najafian B, Mauer M, Hopkin RJ, Svarstad E. Renal complications of Fabry disease in children. Pediatr Nephrol. 2013 May;28(5):679-87. doi: 10.1007/s00467-012-2222-9.</mixed-citation>
     <mixed-citation xml:lang="en">Najafian B, Mauer M, Hopkin RJ, Svarstad E. Renal complications of Fabry disease in children. Pediatr Nephrol. 2013 May;28(5):679-87. doi: 10.1007/s00467-012-2222-9.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Tøndel C., Bostad L., Hirth A., Svarstad E. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis. 2008 May;51(5):767-76. doi:10.1053/j.ajkd.2007.12.032.</mixed-citation>
     <mixed-citation xml:lang="en">Tøndel C., Bostad L., Hirth A., Svarstad E. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis. 2008 May;51(5):767-76. doi:10.1053/j.ajkd.2007.12.032.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Najafian B., Svarstad E., Bostad L., Gubler M. C., Tøndel C., Whitley C., Mauer M. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int. 2011</mixed-citation>
     <mixed-citation xml:lang="en">Najafian B., Svarstad E., Bostad L., Gubler M. C., Tøndel C., Whitley C., Mauer M. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int. 2011</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Generalov E. A., Simonenko E. Yu., Kulchenko N. G., Yakovenko L.V. Molecular basis of biological activity of polysaccharides in COVID-19 associated conditions. Biomeditsinskaya Khimiya. 2022;68(6):403-418. (In Russ.).</mixed-citation>
     <mixed-citation xml:lang="en">Generalov E. A., Simonenko E. Yu., Kulchenko N. G., Yakovenko L.V. Molecular basis of biological activity of polysaccharides in COVID-19 associated conditions. Biomeditsinskaya Khimiya. 2022;68(6):403-418. (In Russ.).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Slobodian E. I., Esatova Z. E, Govdaliuk A. L. Tubulointerstitial kidney diseases in children: focus on the multidisciplinary approach. Crimean Journal of Experimental and Clinical Medicine. 2024;14(3):59-71. (In Russ.).</mixed-citation>
     <mixed-citation xml:lang="en">Slobodian E. I., Esatova Z. E, Govdaliuk A. L. Tubulointerstitial kidney diseases in children: focus on the multidisciplinary approach. Crimean Journal of Experimental and Clinical Medicine. 2024;14(3):59-71. (In Russ.).</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
